PTAB puts a stop to Allergan's tribal sovereign immunity gamble By Annsley Merelle Ward on Sunday, February 25, 2018 allergan AmeriKat IP transactions IPR mylan patent ownership PTAB Sovereign immunity Teva +
US Supreme Court Accepts USPTO "Death Squad (?)" "Broadest Reasonable Construction" Standard By Mike Mireles on Monday, June 27, 2016 in re cuozzo speed technologies inter partes review IPR justice breyer patent trial and appeal board PTAB USPTO +
Hedge funds, pharma patents and thorny issues: a word on IPRs following Lialda By Jeremy on Monday, October 12, 2015 hedge fund inter partes review IPR Jeremy Phillips Kyle bass United States +
Breaking News: PTAB declines Bass hedge fund IPR challenges in Ampyra dispute By Annsley Merelle Ward on Tuesday, August 25, 2015 AmeriKat hedge fund IPR Kyle bass patent validity PTAB US patent law USPTO +
Letter from AmeriKat: Samsung sets sights on Apple Supreme Court fight, Bass's hedge fund model up to bat and Mr Softee takes aim By Annsley Merelle Ward on Saturday, August 22, 2015 AIA AmeriKat apple v samsung design patents hedge fund IPR trade mark infringement us patent litigation US Supreme Court USPTO ustpo +
When things go wrong: inherited claim formats, unforeseen consequences and using IPR to manipulate stock prices By Suleman Ali on Sunday, May 31, 2015 AIA appeal IPR patent reform Swiss claims unintended consequence +